1、 : : 2015 6 2016 6 40 , , 20 , , , 2 3 2 (P) (E2) (LH) (FSH) (PRL) ( ) , 2 : (90.0%) (80.0%) , 2 (P0.05) , 2 (P0.05) , 2 , , 2 (P0.05) , 2 , , , 2 (P 0. 05) , and the volume of uterus and volume of myoma of 2 groups reduced than before treatment ( P 0. 05) , and the reproductive endocrine hormones l
2、evels of 2 groups decreased significantly after treatment. The degree of reduction of observation group was more significant than that of the control group, and there was significant difference between 2 groups ( P 0. 05) , and the whole blood viscosity, high shear and low shear whole blood viscosit
3、y, plasma viscosity, erythrocyte aggregation index, erythrocyte sedimentation rate and fibrinogen levels of 2 groups decreased significantly after treatment. The hematocrit increased significantly, and the improvement degree of the observation group was more significant than that of the control grou
4、p.There was significant difference between 2 groups ( P 0.05) , 1.2 1) 4 : , , ; , ; , , 2) - 5: , : , , 3) 2050 4) (5) , 1.3 1) ;2) ;3) ;4) ;5) ;6) 1.4 1) : ( , H10950003) , 1 , 25 mg/ , 1 /d, , 3 2) : , , : 20 g, 18 g, 15 g, 6 g , 1 /d, 1 , 3 1 , 1 1.5 1) : , 3 , 2) : 57 , (ELISA) (P) (E2) (LH) (F
5、SH) (PRL) 3) : SA-6000 ( ) 1.6 6 , : , , , 90%; : , , 70%89%; : , 1/31/2, , 30%69%; : , , 30% = ( - ) / = ( + + ) / 1.7 SPSS 22.0 , n (%) , t , P0.05) ; 2 (P0.05) ; 2 , , 2 (P0.05) 2 , , , 2 (P0.05) 4 3 , , , , 7 , , , , , 8 , , , , , , , - - , , , 9 , , 10 , , , ; , , , 2 , , , , , , ; , , , , , , , , , , , , , ( ) ( ) , , , , , ; , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , 11; , ; ; , , 12; , ; , , 13; , , , - 14; , , , ; , , ; , , , , , , , 15 , , , , , , , , ,
